Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH

(NASDAQ:AKRO), Investor webcast on Monday, January 27, 2025, at 8:00 a.m. ET to present clinical data SOUTH SAN FRANCISCO, Calif., Jan. 24, 2025 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, will hold an investor conference on […]

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NasdaqGM:TELA), MALVERN, Pa., Jan. 24, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 4,000 shares of its common

Gouverneur Bancorp, Inc. Announces Fiscal 2025 First Quarter Results

(PinkSheets:GOVB),(Pinksheets:GOVB), GOUVERNEUR, N.Y., Jan. 24, 2025 (GLOBE NEWSWIRE) — Gouverneur Bancorp, Inc. (OTCQB: GOVB) (the “Company”), the holding company for Gouverneur Savings and Loan Association (the “Bank”), today announced the Company's results for the first quarter of fiscal year 2025 ended December 31, 2024. The Company reported net income of $160,000, or $0.15 per basic

WEYCO Group, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call

(NASDAQ:WEYS), Milwaukee, WI, Jan. 24, 2025 (GLOBE NEWSWIRE) — WEYCO Group, Inc. (NASDAQ: WEYS), a global marketer of footwear, plans to announce fourth quarter and full year 2024 financial results after the close on Tuesday, March 4, 2025. Additionally, Thomas W. Florsheim, Jr., Chairman and CEO, will host a conference call on Wednesday, March 5,

Lakeland Fire + Safety Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares

HUNTSVILLE, AL / ACCESS Newswire / January 24, 2025 / Lakeland Industries, Inc. ("Lakeland Fire + Safety" or "Lakeland") (NASDAQ:LAKE), a leading global manufacturer of protective clothing for industry, healthcare, and first responders, today announced the closing of its previously announced underwritten public offering of an aggregate of 2,093,000 shares of its common stock at

Ninepoint Partners Announces January 2025 Cash Distributions for ETF Series Securities

(Neo:NBND.NE),(Neo:NACO.NE),(Neo:NRGI.NE),(Neo:TIF.NE), TORONTO, Jan. 24, 2025 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint Partners”) today announced the January 2025 cash distributions for its ETF Series securities. The record date for the distributions is January 31, 2025. All distributions are payable on February 7, 2025. The per-unit January distributions are detailed below: Ninepoint ETF Series Ticker Distribution

Burke & Herbert Financial Services Corp. Announces Fourth Quarter and Full Year 2024 Results and Declares Common Stock Dividend

Burke & Herbert Financial Services Corp. (the “Company” or “Burke & Herbert”) (Nasdaq: BHRB) reported financial results for the quarter and the year ended December31, 2024. In addition, at its meeting on January23, 2025, the board of directors declared a $0.55 per share regular cash dividend to be paid on March3, 2025, to shareholders of

Gamehaus Holdings Inc. and Golden Star Acquisition Corporation Announces Closing of Business Combination and Listing on Nasdaq

Gamehaus Holdings Inc. (“Gamehaus” or the “Company”), a technology-driven mobile game publishing company, and Golden Star Acquisition Corporation (NASDAQ: GODN) (“Golden Star”), a publicly-traded special purpose acquisition company, today announced the completion of their previously announced business combination. The business combination was approved at an extraordinary general meeting of Golden Star's shareholders on January 20,

Kyverna Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Class Action Against KYTX

(NASDAQ:KYTX), SAN DIEGO, Jan. 24, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) and certain of the Company's senior executives and directors who signed the Registration Statement, effective February 7, 2024, issued in connection with the Company's initial public offering (“IPO”). Kyverna

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NasdaqGM:CMRX), DURHAM, N.C., Jan. 24, 2025 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), today announced that on January 17, 2025, the Compensation Committee of Chimerix's Board of Directors granted inducement awards to six new employees of non-statutory stock options to purchase up to a total of 355,000 shares of Chimerix's common stock. The Compensation Committee of Chimerix's

Scroll to Top